Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding

Bibliography

• RIEHM H, BIEDLER JL: Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. Cancer Res. (1972) 32(6):1195-1200.
   PubMed Web of Science ®Google Scholar
• FRICHE E, JENSEN PB, SEHESTED M, DEMANT EJ, NISSEN NN: The solvents Cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer Commun. (1990) 2(9):297-303.
   PubMed Web of Science ®Google Scholar
• COON JS, KNUDSON W, CLODFELTER K, LU B, WEINSTEIN RS: Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Cancer Res. (1991) 51(3):897-902.
   PubMed Web of Science ®Google Scholar
• SPOELSTRA EC, DEKKER H, SCHUURHUIS GJ, BROXTERMAN HJ, LANKELMA J: P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport. Biochem. Pharmacol. (1991) 41(3):349-359.
   PubMed Web of Science ®Google Scholar
• WOODCOCK DM, LINSENMEYER ME, CHOJNOWSKI G et al.: Reversal of multidrug resistance by surfactants. Br. J. Cancer (1992) 66(1):62-68.
   PubMed Web of Science ®Google Scholar
• LOE DW, SHAROM FJ: Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles. Br. J. Cancer (1993) 68(2):342-351.
   PubMed Web of Science ®Google Scholar
• ZORDAN-NUDO T, LING V, LIU Z, GEORGES E: Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. Cancer Res. (1993) 53(24):5994-6000.
   PubMed Web of Science ®Google Scholar
• DRORI S, EYTAN GD, ASSARAF YG: Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur. J. Biochem. (1995) 228(3):1020-1029.
   PubMedGoogle Scholar
• BORREL MN, FIALLO M, VERESS I, GARNIER-SUILLEROT A: The effect of crown ethers, tetraalkylammonium salts, and polyoxyethylene amphiphiles on pirarubicin incorporation in K562 resistant cells. Biochem. Pharmacol. (1995) 50(12):2069-2076.
   PubMed Web of Science ®Google Scholar
• LITMAN T, DRULEY TE, STEIN WD, BATES SE: From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. (2001) 58(7):931-959.
   PubMed Web of Science ®Google Scholar
• STOUCH TR, GUDMUNDSSON O: Progress in understanding the structure–activity relationships of P-glycoprotein. Adv. Drug Deliv. Rev. (2002) 54(3):315-328.
   PubMed Web of Science ®Google Scholar
• CORDON-CARDO C, O’BRIEN JP, CASALS D et al.: Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites. Proc. Natl. Acad. Sci. USA (1989) 86(2):695-698.
   PubMed Web of Science ®Google Scholar
• THIEBAUT F, TSURUO T, HAMADA H, GOTTESMAN MM, PASTAN I, WILLINGHAM MC: Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA (1987) 84(21):7735-7738.
   PubMed Web of Science ®Google Scholar
• TANIGAWARA Y: Role of P-glycoprotein in drug disposition. Ther. Drug Monit. (2000) 22(1):137-140.
   PubMed Web of Science ®Google Scholar
• SEELIG A, GATLIK-LANDWOJTOWICZ E: Inhibitors of multidrug efflux transporters: their membrane and protein interactions. Mini Rev. Med. Chem. (2005) 5(2):135-151.
   PubMed Web of Science ®Google Scholar
• DEAN M, HAMON Y, CHIMINI G: The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. (2001) 42(7):1007-1017.
   PubMed Web of Science ®Google Scholar
• ZAMEK-GLISZCZYNSKI MJ, HOFFMASTER KA, NEZASA K, TALLMAN MN, BROUWER KL: Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur. J. Pharm. Sci. (2006) 27(5):447-486.
   PubMed Web of Science ®Google Scholar
• SEELIG A, BLATTER XL, WOHNSLAND F: Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. Int. J. Clin. Pharmacol. Ther. (2000) 38(3):111-121.
   PubMed Web of Science ®Google Scholar
• ZHANG Y, BENET LZ: The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin. Pharmacokinet. (2001) 40(3):159-168.
   PubMed Web of Science ®Google Scholar
• HIGGINS CF, GOTTESMAN MM: Is the multidrug transporter a flippase? Trends Biochem. Sci. (1992) 17(1):18-21.
   PubMed Web of Science ®Google Scholar
• GATLIK-LANDWOJTOWICZ E, AANISMAA P, SEELIG A: Quantification and characterization of P-glycoprotein-substrate interactions. Biochemistry (2006) 45(9):3020-3032.
   PubMed Web of Science ®Google Scholar
• ORLOWSKI S, SELOSSE MA, BOUDON C et al.: Effects of detergents on P-glycoprotein atpase activity: differences in perturbations of basal and verapamil-dependent activities. Cancer Biochem. Biophys. (1998) 16(1-2):85-110.
   PubMedGoogle Scholar
• REGEV R, ASSARAF YG, EYTAN GD: Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. Eur. J. Biochem. (1999) 259(1-2):18-24.
   PubMedGoogle Scholar
• MEIER M, LI-BLATTER X, SEELIG A, SEELIG J: Interaction of verapamil with lipid membranes and P-glycoprotein. Connecting thermodynamics and membrane structure with functional activity. Biophysical J. (In Press).
   Google Scholar
• WAKITA M, KURODA Y, NAKAGAWA T: Interactions between local anesthetic dibucaine and pig erythrocyte membranes as studied by proton and phosphorus-31 nuclear magnetic resonance spectroscopy. Chem. Pharm. Bull. (Tokyo) (1992) 40(6):1361-1365.
   PubMed Web of Science ®Google Scholar
• REGE BD, KAO JP, POLLI JE: Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur. J. Pharm. Sci. (2002) 16(4-5):237-246.
   PubMed Web of Science ®Google Scholar
• NERVI P: Peptide and drug interactions in murine models in vitro and in vivo studies with microphysiometry, confocal microscopy and functional magnetic resonance imaging. PhD Thesis, University of Basel, Switzerland (2004).
   Google Scholar
• KABANOV AV, BATRAKOVA EV, MILLER DW: Pluronic block copolymers as modulators of drug efflux transporter activity in the blood–brain barrier. Adv. Drug Deliv. Rev. (2003) 55(1):151-164.
   PubMed Web of Science ®Google Scholar
• SEELIG J, SEELIG A: Lipid conformation in model membranes and biological membranes. Q. Rev. Biophys. (1980) 13(1):19-61.
   PubMed Web of Science ®Google Scholar
• SEELIG A, SEELIG J: Membrane Structure. In: Encyclopedia of Physical Science and Technology, 3rd edn. Academic Press, NY, USA (2002):355-367.
   Google Scholar
• LITMAN T, NIELSEN D, SKOVSGAARD T, BUKHAVE K: Lipid composition of sensitive and multidrug resistant Ehrlich ascites tumour cells. Cell. Pharmacol. (1995) 2:9-14.
   Google Scholar
• FISCHER H, GOTTSCHLICH R, SEELIG A: Blood–brain barrier permeation: molecular parameters governing passive diffusion. J. Membr. Biol. (1998) 165(3):201-211.
   PubMed Web of Science ®Google Scholar
• FISCHER H, SEELIG A, CHOU RC, VAN DE WATERBEEMD J: The difference between the diffusion through the blood–brain barrier and the gastro-intestinal membrane. 4th International Conference on Drug Absorption. Edinburgh, UK (1997).
   Google Scholar
• SEELIG A: Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. Biochim. Biophys. Acta (1987) 899(2):196-204.
   PubMed Web of Science ®Google Scholar
• BOGUSLAVSKY V, REBECCHI M, MORRIS AJ, JHON DY, RHEE SG, MCLAUGHLIN S: Effect of monolayer surface pressure on the activities of phosphoinositide-specific phospholipase C-β1, -γ1, and -δ1. Biochemistry (1994) 33(10):3032-3037.
   PubMed Web of Science ®Google Scholar
• GEREBTZOFF G, LI-BLATTER X, FISCHER H, FRENTZEL A, SEELIG A: Halogenation of drugs enhances membrane binding and permeation. Chembiochem (2004) 5(5):676-684.
   PubMed Web of Science ®Google Scholar
• GOBAS FA, LAHITTETE JM, GAROFALO G, SHIU WY, MACKAY D: A novel method for measuring membrane-water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol–water partitioning. J. Pharm. Sci. (1988) 77(3):265-272.
   PubMed Web of Science ®Google Scholar
• HEERKLOTZ H, SEELIG J: Correlation of membrane/water partition coefficients of detergents with the critical micelle concentration. Biophys. J. (2000) 78(5):2435-2440.
   PubMed Web of Science ®Google Scholar
• WU G, MAJEWSKI J, EGE C, KJAER K, WEYGAND MJ, LEE KY: Lipid corralling and poloxamer squeeze-out in membranes. Phys. Rev. Lett. (2004) 93(2):028101.
   Google Scholar
• MASKARINEC SA, HANNIG J, LEE RC, LEE KY: Direct observation of poloxamer 188 insertion into lipid monolayers. Biophys. J. (2002) 82(3):1453-1459.
   PubMed Web of Science ®Google Scholar
• WU G, MAJEWSKI J, EGE C, KJAER K, WEYGAND MJ, LEE KY: Interaction between lipid monolayers and poloxamer 188: an X-ray reflectivity and diffraction study. Biophys. J. (2005) 89(5):3159-3173.
   PubMed Web of Science ®Google Scholar
• CHANG LC, LIN CY, KUO MW, GAU CS: Interactions of Pluronics with phospholipid monolayers at the air–water interface. J. Colloid Interface Sci. (2005) 285(2):640-652.
   PubMed Web of Science ®Google Scholar
• KRYLOVA OO, POHL P: Ionophoric activity of pluronic block copolymers. Biochemistry (2004) 43(12):3696-3703.
   PubMed Web of Science ®Google Scholar
• DEMINA T, GROZDOVA I, KRYLOVA O et al.: Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers. Biochemistry (2005) 44(10):4042-4054.
   PubMed Web of Science ®Google Scholar
• BATRAKOVA EV, MILLER DW, LI S, ALAKHOV VY, KABANOV AV, ELMQUIST WF: Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J. Pharmacol. Exp. Ther. (2001) 296(2):551-557.
   PubMed Web of Science ®Google Scholar
• OTTEN D, BROWN MF, BEYER K: Softening of membrane bilayers by detergents elucidated by deuterium NMR spectroscopy. J. Phys. Chem. B (2000) 104:12119-12129.
   Web of Science ®Google Scholar
• THEWALT JL, TULLOCH AP, CUSHLEY RJ: A deuterium NMR study of labelled n-alkanol anesthetics in a model membrane. Chem. Phys. Lipids (1986) 39(1-2):93-107.
   PubMed Web of Science ®Google Scholar
• WENK MR, ALT T, SEELIG A, SEELIG J: Octyl-β-d-glucopyranoside partitioning into lipid bilayers: thermodynamics of binding and structural changes of the bilayer. Biophys. J. (1997) 72(4):1719-1731.
   PubMed Web of Science ®Google Scholar
• HEERKLOTZ H: Triton promotes domain formation in lipid raft mixtures. Biophys. J. (2002) 83(5):2693-2701.
   PubMed Web of Science ®Google Scholar
• WASSALL SR, THEWALT JL, WONG L, GORRISSEN H, CUSHLEY RJ: Deuterium NMR study of the interaction of α-tocopherol with a phospholipid model membrane. Biochemistry (1986) 25(2):319-326.
   PubMed Web of Science ®Google Scholar
• HUGGER ED, NOVAK BL, BURTON PS, AUDUS KL, BORCHARDT RT: A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J. Pharm. Sci. (2002) 91(9):1991-2002.
   PubMed Web of Science ®Google Scholar
• LIANG X, MAO G, NG KY: Effect of chain lengths of PEO-PPO-PEO on small unilamellar liposome morphology and stability: an AFM investigation. J. Colloid Interface Sci. (2005) 285(1):360-372.
   PubMed Web of Science ®Google Scholar
• OMOTE H, AL-SHAWI MK: Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism. Biophys. J. (2006) 90(11):4046-4059.
   PubMed Web of Science ®Google Scholar
• SEELIG A, LANDWOJTOWICZ E, FISCHER H, BLATTER XL: Towards P-glycoprotein structure–activity relationships. In: Drug bioavailability/Estimation of solubility, permeability, absorption and bioavailability. Van der Waterbeemd H, Lennernas H, Arthurson P (Eds), Wiley-VCH Verlag GmbH, Weinheim, Germany (2003).
   Google Scholar
• SEELIG A: A general pattern for substrate recognition by P-glycoprotein. Eur. J. Biochem. (1998) 251(1-2):252-261.
   PubMedGoogle Scholar
• ECKER G, HUBER M, SCHMID D, CHIBA P: The importance of a nitrogen atom in modulators of multidrug resistance. Mol. Pharmacol. (1999) 56(4):791-796.
   PubMed Web of Science ®Google Scholar
• SEELIG A, LANDWOJTOWICZ E: Structure–activity relationship of P-glycoprotein substrates and modifiers. Eur. J. Pharm. Sci. (2000) 12(1):31-40.
   PubMed Web of Science ®Google Scholar
• CHIBA P, ERKER T, GALANSKI M, HITZLER M, ECKER GF: Synthesis and multidrug-resistance modulating activity of a series of thienothiazines. Arch. Pharm. (Weinheim) (2002) 335(5):223-228.
   Web of Science ®Google Scholar
• SEELIG A: Unraveling membrane-mediated substrate–transporter interactions. Biophys. J. (2006) 90(11):3825-3826.
   PubMed Web of Science ®Google Scholar
• LANDWOJTOWICZ E, NERVI P, SEELIG A: Real-time monitoring of P-glycoprotein activation in living cells. Biochemistry (2002) 41(25):8050-8057.
   PubMed Web of Science ®Google Scholar
• AL-SHAWI MK, POLAR MK, OMOTE H, FIGLER RA: Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein. J. Biol. Chem. (2003) 278(52):52629-52640.
   PubMed Web of Science ®Google Scholar
• RAGGERS RJ, POMORSKI T, HOLTHUIS JC, KALIN N, VAN MEER G: Lipid traffic: the ABC of transbilayer movement. Traffic (2000) 1(3):226-234.
   PubMed Web of Science ®Google Scholar
• ROMSICKI Y, SHAROM FJ: Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. Biochemistry (2001) 40(23):6937-6947.
   PubMed Web of Science ®Google Scholar
• LITMAN T, ZEUTHEN T, SKOVSGAARD T, STEIN WD: Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity. Biochim. Biophys. Acta (1997) 1361(2):159-168.
   PubMed Web of Science ®Google Scholar
• GATLIK-LANDWOJTOWICZ E, AANISMAA P, SEELIG A: The rate of P-glycoprotein activation depends on the metabolic state of the cell. Biochemistry (2004) 43(46):14840-14851.
   PubMed Web of Science ®Google Scholar
• URBATSCH IL, AL-SHAWI MK, SENIOR AE: Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein. Biochemistry (1994) 33(23):7069-7076.
   PubMed Web of Science ®Google Scholar
• SHAPIRO AB, LING V: Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein. Eur. J. Biochem. (1998) 254(1):189-193.
   PubMedGoogle Scholar
• SAUNA ZE, AMBUDKAR SV: Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes. J. Biol. Chem. (2001) 276(15):11653-11661.
   PubMed Web of Science ®Google Scholar
• NERURKAR MM, HO NF, BURTON PS, VIDMAR TJ, BORCHARDT RT: Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. J. Pharm. Sci. (1997) 86(7):813-821.
   PubMed Web of Science ®Google Scholar
• BRAVO GONZALEZ RC, HUWYLER J, BOESS F, WALTER I, BITTNER B: In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS-15 on the metabolism of midazolam. Biopharm. Drug Dispos. (2004) 25(1):37-49.
   PubMed Web of Science ®Google Scholar
• BITTNER B, GONZALEZ RC, WALTER I, KAPPS M, HUWYLER J: Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats. Biopharm. Drug Dispos. (2003) 24(4):173-181.
   PubMed Web of Science ®Google Scholar
• BRAVO GONZALEZ RC, HUWYLER J, WALTER I, MOUNTFIELD R, BITTNER B: Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension. Int. J. Pharm. (2002) 245(1-2):143-151.
   PubMedGoogle Scholar
• BITTNER B, GONZALEZ RCB, WALTER I, HUWYLER J: Impact of oral administration of the surface-active excipient solutol HS-15 on the pharmacokinetics of intravenously administered colchicine. Lett. Drug Des. Disc. (2005) 2(3):193-195.
   Web of Science ®Google Scholar
• WANG SW, MONAGLE J, MCNULTY C, PUTNAM D, CHEN H: Determination of P-glycoprotein inhibition by excipients and their combinations using an integrated high-throughput process. J. Pharm. Sci. (2004) 93(11):2755-2767.
   PubMed Web of Science ®Google Scholar
• DUDEJA PK, ANDERSON KM, HARRIS JS, BUCKINGHAM L, COON JS: Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Arch. Biochem. Biophys. (1995) 319(1):309-315.
   PubMed Web of Science ®Google Scholar
• LITMAN T, SKOVSGAARD T, STEIN WD: Pumping of drugs by P-glycoprotein: a two-step process? J. Pharmacol. Exp. Ther. (2003) 307(3):846-853.
   PubMed Web of Science ®Google Scholar
• ATTWOOD D, FLORENCE AT: Surfactant systems: their chemistry, pharmacy and biology. Chapman and Hall, London (UK) and New York (USA) (1983).
   Google Scholar
• BOGMAN K, ZYSSET Y, DEGEN L et al.: P-glycoprotein and surfactants: effect on intestinal talinolol absorption. Clin. Pharmacol. Ther. (2005) 77(1):24-32.
   PubMed Web of Science ®Google Scholar
• JAGANNATH C, WELLS A, MSHVILDADZE M et al.: Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL-1605 copolymer. Life Sci. (1999) 64(19):1733-1738.
   PubMed Web of Science ®Google Scholar
• BANERJEE SK, JAGANNATH C, HUNTER RL, DASGUPTA A: Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein. Life Sci. (2000) 67(16):2011-2016.
   PubMed Web of Science ®Google Scholar
• GAUCHER G, DUFRESNE MH, SANT VP, KANG N, MAYSINGER D, LEROUX JC: Block copolymer micelles: preparation, characterization and application in drug delivery. J. Control. Release (2005) 109(1-3):169-188.
   PubMed Web of Science ®Google Scholar
• GELDERBLOM H, VERWEIJ J, NOOTER K, SPARREBOOM A: Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer (2001) 37(13):1590-1598.
   PubMed Web of Science ®Google Scholar
• COORS EA, SEYBOLD H, MERK HF, MAHLER V: Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Ann. Allergy Asthma Immunol. (2005) 95(6):593-599.
   PubMed Web of Science ®Google Scholar
• HAVEL M, MULLER M, GRANINGER W, KURZ R, LINDEMAYR H: Tolerability of a new vitamin K1 preparation for parenteral administration to adults: one case of anaphylactoid reaction. Clin. Ther. (1987) 9(4):373-379.
   PubMed Web of Science ®Google Scholar
• THEIS JG, LIAU-CHU M, CHAN HS, DOYLE J, GREENBERG ML, KOREN G: Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL. J. Clin. Oncol. (1995) 13(10):2508-2516.
   PubMed Web of Science ®Google Scholar
• PENDSE S, SAYEGH MH, FRANK MH: P-glycoprotein-a novel therapeutic target for immunomodulation in clinical transplantation and autoimmunity? Curr. Drug Targets (2003) 4(6):469-476.
   PubMed Web of Science ®Google Scholar
• BEGLEY GS, HORVATH AR, TAYLOR JC, HIGGINS CF: Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. Mol. Immunol. (2005) 42(1):137-141.
   PubMed Web of Science ®Google Scholar
• COGGER VC, HILMER SN, SULLIVAN D, MULLER M, FRASER R, LE COUTEUR DG: Hyperlipidemia and surfactants: the liver sieve is a link. Atherosclerosis (2006) (In Press).
   PubMedGoogle Scholar
• SEEBALLUCK F, ASHFORD MB, O’DRISCOLL CM: The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells. Pharm. Res. (2003) 20(7):1085-1092.
   PubMed Web of Science ®Google Scholar
• JOHNSON BM, CHARMAN WN, PORTER CJ: An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine. AAPS PharmSci (2002) 4(4):40.
   PubMedGoogle Scholar
• BATRAKOVA EV, LI S, MILLER DW, KABANOV AV: Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm. Res. (1999) 16(9):1366-1372.
   PubMed Web of Science ®Google Scholar
• MILLER DW, BATRAKOVA EV, KABANOV AV: Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers. Pharm. Res. (1999) 16(3):396-401.
   PubMed Web of Science ®Google Scholar
• BOGMAN K, ERNE-BRAND F, ALSENZ J, DREWE J: The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. J. Pharm. Sci. (2003) 92(6):1250-1261.
   PubMed Web of Science ®Google Scholar
• DEMEL RA, GEURTS VAN KESSEL WS, ZWAAL RF, ROELOFSEN B, VAN DEENEN LL: Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. Biochim. Biophys. Acta (1975) 406(1):97-107.
   PubMed Web of Science ®Google Scholar
• BLUME A: A comparative study of the phase transitions of phospholipid bilayers and monolayers. Biochim. Biophys. Acta (1979) 557(1):32-44.
   PubMed Web of Science ®Google Scholar
• NERVI P, LI BLATTER X, SEELIG A: Surfactants as P-glycoprotein substrates and inhibitors. (In preparation).
   Google Scholar
• BRAVO GONZALEZ RC, BOESS F, DURR E, SCHAUB N, BITTNER B: In vitro investigation on the impact of Solutol HS 15 on the uptake of colchicine into rat hepatocytes. Int. J. Pharm. (2004) 279(1-2):27-31.
   PubMedGoogle Scholar
• BITTNER B, GUENZI A, FULLHARDT P, ZUERCHER G, GONZALEZ RC, MOUNTFIELD RJ: Improvement of the bioavailability of colchicine in rats by co-administration of d-α-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid. Arzneimittelforschung (2002) 52(9):684-688.
   PubMed Web of Science ®Google Scholar
• DINTAMAN JM, SILVERMAN JA: Inhibition of P-glycoprotein by d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm. Res. (1999) 16(10):1550-1556.
   PubMed Web of Science ®Google Scholar
• REBBEOR JF, SENIOR AE: Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form. Biochim. Biophys. Acta (1998) 1369(1):85-93.
   PubMed Web of Science ®Google Scholar
• LO YL: Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J. Control. Release (2003) 90(1):37-48.
   PubMed Web of Science ®Google Scholar
• HIRSCH-ERNST KI, ZIEMANN C, RUSTENBECK I, KAHL GF: Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures. Toxicology (2001) 167(1):47-57.
   PubMed Web of Science ®Google Scholar